Business Description
Revolution Medicines Inc
NAICS : 325411
SIC : 2833
ISIN : US76155X1000
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.2 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 24.01 | |||||
Beneish M-Score | -17.03 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -49.3 | |||||
3-Year EBITDA Growth Rate | -27 | |||||
3-Year EPS without NRI Growth Rate | -24.3 | |||||
3-Year FCF Growth Rate | -19 | |||||
3-Year Book Growth Rate | 15.9 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 77.96 | |||||
9-Day RSI | 70.15 | |||||
14-Day RSI | 64.83 | |||||
6-1 Month Momentum % | 36.96 | |||||
12-1 Month Momentum % | 58.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 15.42 | |||||
Quick Ratio | 15.42 | |||||
Cash Ratio | 15.1 | |||||
Days Sales Outstanding | 992.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35.2 | |||||
Shareholder Yield % | -0.22 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -80961.32 | |||||
Net Margin % | -69973.99 | |||||
FCF Margin % | -70756.91 | |||||
ROE % | -37.41 | |||||
ROA % | -33.13 | |||||
ROIC % | -308.12 | |||||
3-Year ROIIC % | -463.85 | |||||
ROC (Joel Greenblatt) % | -618.23 | |||||
ROCE % | -37.73 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 9470 | |||||
PB Ratio | 4.84 | |||||
Price-to-Tangible-Book | 5.07 | |||||
EV-to-EBIT | -11.58 | |||||
EV-to-Forward-EBIT | -8.43 | |||||
EV-to-EBITDA | -11.81 | |||||
EV-to-Forward-EBITDA | -8.6 | |||||
EV-to-Revenue | 8633.41 | |||||
EV-to-Forward-Revenue | 355.89 | |||||
EV-to-FCF | -12.31 | |||||
Price-to-Net-Current-Asset-Value | 5.47 | |||||
Price-to-Net-Cash | 5.59 | |||||
Earnings Yield (Greenblatt) % | -8.64 | |||||
FCF Yield % | -6.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Revolution Medicines Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.68 | ||
EPS (TTM) (€) | -3.434 | ||
Beta | 1.86 | ||
Volatility % | 61.47 | ||
14-Day RSI | 64.83 | ||
14-Day ATR (€) | 1.054901 | ||
20-Day SMA (€) | 39.89 | ||
12-1 Month Momentum % | 58.82 | ||
52-Week Range (€) | 17.1 - 43.6 | ||
Shares Outstanding (Mil) | 167.04 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Revolution Medicines Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Revolution Medicines Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Revolution Medicines Inc Frequently Asked Questions
What is Revolution Medicines Inc(STU:42Z)'s stock price today?
When is next earnings date of Revolution Medicines Inc(STU:42Z)?
Does Revolution Medicines Inc(STU:42Z) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |